Trial of the efficacy and safety of CG428 lotion against the adjuvant chemotherapy induced alopecia in breast cancer patients.
Phase 2
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000026955
- Lead Sponsor
- St.Marianna University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 64
Inclusion Criteria
Not provided
Exclusion Criteria
1) Known allergy or hypersensitivity to some components of CG428. 2) Patients with recent (within 3 months) usage of other anti-hair-loss treatments. 3) Previous use of other anti-hair-loss treatment or hair growth treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method